Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices

BACKGROUND: Myelosuppression is a major dose‐limiting complication of chemotherapy for patients with extensive‐stage small cell lung cancer (ES‐SCLC). The objective was to describe the burden of myelosuppression, treatment patterns, and supportive care use among patients with ES‐SCLC treated with ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Hart, Lowell, Ogbonnaya, Augustina, Boykin, Kristen, Deyoung, Kathryn, Bailey, Ray, Heritage, Trevor, Lopez‐Gonzalez, Lorena, Huang, Huan, Gordan, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166910/
https://www.ncbi.nlm.nih.gov/pubmed/37000119
http://dx.doi.org/10.1002/cam4.5738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166910/
https://www.ncbi.nlm.nih.gov/pubmed/37000119
http://dx.doi.org/10.1002/cam4.5738

Ejemplares similares